Content on this website is intended for healthcare professionals only.

By clicking on the link below, you confirm you are a healthcare professional (HCP).

I confirm I am a HCP I am not a HCP


EASD 2020: Reduction of CV Events by GLP-1 RAs Explained by HbA1c Reduction

Published: 20 Nov 2020

  • Views:

    Views Icon 67
  • Likes:

    Heart Icon 0

Dr Mart Roosimaa explores the relationship between CV event reduction, GLP-1 RAs and HbA1c. in lowering the reduction of CV risk in T2DM patients. 

Recorded remotely from Tartu, Estonia, 2020

Recording Editor: Michael Knight

This presentation was supported by an unrestricted educational grant from Novo Nordisk